Abbott Laboratories (ABT) Total Debt Growth (3y) (2012 - 2026)
Abbott Laboratories (ABT) Total Debt Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 24.63% |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 4.89% |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 11.72% |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 0.11% |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | -0.47% |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | -1.01% |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | -13.48% |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn | 9.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 24.63% |
| Mar 31, 2026 | 26.30% |
| Dec 31, 2025 | -12.08% |
| Sep 30, 2025 | -7.62% |
| Jun 30, 2025 | -7.10% |
| Mar 31, 2025 | -8.15% |
| Dec 31, 2024 | -5.99% |
| Sep 30, 2024 | -6.29% |
| Jun 30, 2024 | -6.93% |
| Mar 31, 2024 | -7.19% |
| Dec 31, 2023 | -5.61% |
| Sep 30, 2023 | -5.77% |
| Jun 30, 2023 | -4.72% |
| Mar 31, 2023 | -2.20% |
| Dec 31, 2022 | 1.98% |
| Sep 30, 2022 | -4.58% |
| Jun 30, 2022 | -4.41% |
| Mar 31, 2022 | -3.55% |
| Dec 31, 2021 | -1.30% |
| Sep 30, 2021 | -7.97% |